NYSE American - Nasdaq Real Time Price USD

Matinas BioPharma Holdings, Inc. (MTNB)

Compare
0.6797 +0.1247 (+22.66%)
As of 1:38 PM EST. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
25,104.0000
44,819.0000
61,326.0000
70,967.3060
Total Liabilities Net Minority Interest
5,858.0000
8,182.0000
8,832.0000
7,236.6090
Total Equity Gross Minority Interest
19,246.0000
36,637.0000
52,494.0000
63,730.6970
Total Capitalization
19,246.0000
36,637.0000
52,494.0000
63,730.6970
Preferred Stock Equity
--
--
--
3,797.7050
Common Stock Equity
19,246.0000
36,637.0000
52,494.0000
59,932.9920
Capital Lease Obligations
3,556.0000
4,124.0000
4,703.0000
3,750.0740
Net Tangible Assets
14,893.0000
32,284.0000
48,141.0000
59,376.8320
Working Capital
12,921.0000
30,246.0000
46,645.0000
57,987.2240
Invested Capital
19,246.0000
36,637.0000
52,494.0000
59,932.9920
Tangible Book Value
14,893.0000
32,284.0000
48,141.0000
55,579.1270
Total Debt
3,556.0000
4,124.0000
4,703.0000
3,750.0740
Share Issued
217,264.5260
217,264.5260
216,269.4500
200,113.4310
Ordinary Shares Number
217,264.5260
217,264.5260
216,269.4500
200,113.4310
12/31/2020 - 7/21/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers